Presage Biosciences
Presage Biosciences is a local Seattle-area company in which Bristol Myers Squibb holds investments, mentioned in contexts about cancer...
Facts
- Sectors
- Biotechnology, Life Sciences, Cancer research
- Founded
- 2010 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Presage Biosciences Inc Seattle business license
Recent coverage
Front-page news, podcasts and videos about Presage Biosciences
Presage Biosciences raises $13M, inks collaborations with Merck and Maverick to test cancer drugs using CIVO
Seattle-based Presage Biosciences raised $13 million in its first venture round, bringing total equity to $35 million, and announced new collaborations with Merck and Maverick Therapeutics to use its CIVO platform for testing cancer drugs in human tumors. The CIVO device enables micro-dosing and biomarker tracking in phase 0 trials, aiming to improve preclinical screening and reduce failures in costly phase I trials.
